Implicity

Implicity is a Paris and Cambridge (MA) healthtech company providing AI-driven remote monitoring for patients with pacemakers and implantable defibrillators. Founded in 2016 by cardiac electrophysiologist Arnaud Rosier, the platform aggregates data from multiple device makers and hospital records, with Signal HF predicting hospitalisation risk (FDA-cleared) and productivity AI reducing false alarms using clinical context; company-cited outcomes include about 26% lower mortality. After a $23 million Series A in 2022 (Crédit Mutuel Innovation / Bpifrance and others), Implicity raised €35 million growth funding in September 2026 led by IRIS and Five Arrows (Rothschild & Co) to expand commercially in the US and Germany and pursue tuck-in acquisitions, bringing total capital raised to roughly $69 million. Sources: Tech Funding News / EU-Startups 9 Sep 2026; Implicity.